ClinConnect ClinConnect Logo
Search / Trial NCT01847131

Effectiveness of Oxymetazoline Added on Nasal Steroid in Rhinitis With Persistent Nasal Obstruction

Launched by MAHIDOL UNIVERSITY · May 1, 2013

Trial Information

Current as of April 30, 2025

Completed

Keywords

Rhinitis Oxymetazoline

ClinConnect Summary

All participants will continue medications for 4 weeks, then stop using interventional medication and still take INS (2 puffs in each nostril twice daily) and OAH (1 tablet once daily) for 2 more weeks. Then, all participants will come for the last visit to see whether rebound nasal symptoms occur. Participants will be asked to record nasal symptom diary card, and nasal peak inspiratory flow. Rhinoconjunctivitis Quality of life Questionnaire (Rcq) will be recorded during visit.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient 18 years of age or greater
  • Diagnosis with allergic or nonallergic rhinitis with persistent nasal obstruction
  • Being treated with intranasal steroid and oral antihistamine
  • Exclusion Criteria:
  • Underlying disease of hypertension
  • Use oral or nasal decongestant 7 days prior to entering the study
  • Nasal polyp or significant deviated nasal septum
  • Respiratory tract infection 14 days prior to entering the study

About Mahidol University

Mahidol University, a premier institution in Thailand, is dedicated to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the university leverages its extensive expertise in medical and health sciences to facilitate rigorous scientific investigations aimed at improving patient care and public health outcomes. With a commitment to ethical practices and collaboration, Mahidol University fosters multidisciplinary approaches, engaging a diverse array of researchers and healthcare professionals to drive meaningful advancements in clinical research.

Locations

Bangkok, , Thailand

Patients applied

0 patients applied

Trial Officials

Torpong Thongngarm, M.D.

Principal Investigator

Mahidol University

Panitan Pradubpongsa, M.D.

Study Chair

Mahidol University

Paraya Assanasen, M.D.

Study Chair

Mahidol University

Pongsakorn Tantilipikorn, M.D.

Study Chair

Mahidol University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials